Bioconjugation of laminin-related peptide YIGSR with polyvinyl pyrrolidone increases its antimetastatic effect due to a longer plasma half-life

Biochemical and Biophysical Research Communications

Volumn 264, Issue 3, 1999, Pages 763-767

  Mu, Yu ^a   Kamada, Haruhiko ^a   Kodaira, Hiroshi ^a   Sato, Keiko ^a   Tsutsumi, Yasuo ^a   Maeda, Mistuko ^b   Kawasaki, Koichi ^b   Nomizu, Motoyoshi ^c   Yamada, Yoshihiko ^c   Mayumi, Tadanori ^a  

^a OSAKA UNIVERSITY   (Japan)

^b KOBE GAKUIN UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Antimetastasis; Peptide modification; Plasma half life; Polyvinyl pyrrolidone; Stability; YIGSR

Indexed keywords

ANTIMETASTATIC AGENT; LAMININ; POVIDONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONJUGATION; DRUG HALF LIFE; DRUG STABILITY; INTRAVENOUS DRUG ADMINISTRATION; LUNG METASTASIS; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0033517756     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1999.1567     Document Type: Article

References (23)

1. Poste G., Filder I. J. Nature. 283:1982;139-146.
2. Ariyoshi Y. Exp. Med. 16:1998;177-182.
3. Filder I. J. Cancer Invasion and Metastasis. 1984;Raven Press, New York. p. 5-26.
4. Liotla L. A., Rao C. N., Barsky S. H. Lab. Invest. 49:1983;636-649.
5. Terranova V. P., Hujanen E. S., Martin G. R. J. Natl. Cancer Inst. 77:1986;311-316.
6. McCarthy J. B., Furcht L. T. J. Cell Biol. 98:1984;1474-1480.
7. Kleinman H. K., Weeks B. S., Schnaper H. W., Kibbey M. C., Yamamura K., Grant D. S. Vita Horm. 47:1993;161-186.
8. Iwamoto Y., Robey F. A., Graf J., Sasaki M., Kleinman H. K., Yamada Y., Martin G. R. Science. 238:1987;1132-1134.
9. Lee V. H. L. Peptide and Protein Drug Delivery. 1991.
10. Tsutsumi Y., Kihira T., Tsunoda S., Kanamori T., Nakagawa S., Mayumi T. Br. J. Cancer. 71:1995;963-968.
11. Tsutsumi Y., Tsunoda S., Kamada H., Kihira T., Kaneda Y., Ohsugi Y., Mayumi T. Thromb. Haemostas. 77:1997;168-173.
12. Kaneda Y., Yamamoto Y., Kamada H., Tsunoda S., Tsutsumi Y., Hirano T., Mayumi T. Cancer Res. 58:1998;290-295.
13. Kawasaki K., Namikawa M., Murakami T., Mizuta T., Iwa Y., Hama T., Mayumi T. Biochem. Biophys. Res. Commun. 174:1991;1159-1162.
14. Kaneda Y., Yamamoto S., Kihira T., Tsutsumi Y., Nakagawa S., Miyake M., Kawasaki K., Mayumi T. Invas. Metastasis. 15:1995;156-162.
15. Meffifield R. B. J. Am. Chem. Soc. 85:1963;2149-2145.
16. Kamada H., Tsutsumi Y., Tsunoda S., Kihira T., Kaneda Y., Yamamoto Y., Nakagawa S., Horisawa Y., Mayumi T. Biochem. Biophys. Res. Commun. 257:1999;448-453.
17. Udenfriend S., Stein S., Bohlen P., Dairman W. Science. 178:1972;871-872.
18. Filder I. J. Nature. 242:1973;148-151.
19. Hunter W. M., Greenwood F. C. Nature. 227:1962;495-496.
20. Marquardt D. W. J. Soc. Ind. Appl. Math. 11:1963;431-441.
21. Tsutsumi Y., Tsunoda S., Kamada H., Kihira T., Kaneda Y., Kanamori T., Nakagawa S., Mayumi T. Br. J. Cancer. 74:1996;1090-1095.
22. Yamamoto S., Kaneda Y., Okada N., Nagawa S., Kubo K., Inoue S., Maeda M., Yoshihiro Y., Kawasaki K., Mayumi T. Anti-Cancer Drugs. 5:1994;424-428.
23. Mu Y., Kamada H., Kaneda Y., Yamamoto Y., Kodaira H., Tsunoda S., Tsutsumi Y., Maeda M., Kawasaki K., Nomizu M., Yamada Y., Mayumi T. Biochem. Biophys. Res. Commun. 255:1999;75-79.